I can't believe I just pinpointed the worst stock in the stock market... AGAIN. I want to show you how to profit up to 500% from its collapse. This dog reminds me almost exactly of the biopharma formerly called Valeant's stock, one I accurately predicted would plummet before its monumental 93% collapse. It was the fall of 2015, and I delivered a presentation on Valeant to a group of analysts, writers and researchers in Florida... Valeant, at the time, was a $61 BILLION Wall Street darling... The stock was up 882% over five years... Billionaire Bill Ackman was all-in. But I smelled trouble... You see, Valeant wasn't developing its own drugs... Instead, it was buying up other drug companies like a serial acquirer. There were multiple financial misstatements taking place. I proved how Valeant was similar to Enron, WorldCom and Tyco, all of which cost investors their shirts. To sum it up: Valeant was a house of cards, and I knew it. But I presented a unique way to play it... so investors could still make up to 500% as Valeant's stock fell. It began its 93% collapse virtually the day after my presentation. Billionaire Bill Ackman "lost $7.7 million per day" as he kept holding on for dear life. 
In total, he lost $4 BILLION. "A huge mistake," he'd later admit. And what I'm seeing from the WORST biotech in today's markets... It reminds me so much of Valeant's stock. For one, this biotech has never successfully developed nor commercialized a drug in its 40-year history. 40 years! Instead, it pitches story after story, claiming to have a big cure. Investors come in and get duped into believing it. And then, when it doesn't work out, the investors are out of luck. The company recently claimed to have created a coronavirus vaccine in just three hours. Here's a statement from its CEO: "By getting just the DNA sequence of the virus, we were able to fully construct our vaccine within three hours." At first glance, that's some jaw-dropping stuff, right? However, investigative firm Citron Research, led by Andrew Left, a short seller known for exposing accounting fraud at Valeant... ahem... VALEANT... spotted something fishy. Citron Research called on the SEC to halt trading on this biotech and to launch an investigation into the "ludicrous and dangerous claim that they designed a vaccine in three hours." 
To be clear, the company insists it's done nothing wrong or misleading. However, an investor class-action lawsuit just hit the company... According to Yahoo Finance, "The plaintiff says that (the company) knew it had not developed a vaccine for COVID-19, that such a vaccine could not be developed in a matter of hours." Ouch. Look, this company's exactly like Valeant... - It's made misstatements.
- It's under investigation for potential fraud.
- It's got a clown-show CEO.
It's wrong to suggest it has a vaccine for the coronavirus when it has no such thing. But we're going to profit from it anyway. No, we're not going to buy the stock and sell it to the next fool who believes this company's garbage press releases. We're going to make this... ONE. EASY. MOVE.
To holding companies accountable, Marc P.S. This situation is urgent, because when investors pile out of a stock, the price can fall very quickly. Get the details now.
P.P.S.Click the link above and I'll also show you the company I believe is the runaway leader in the race to a coronavirus cure. | 
No comments:
Post a Comment